These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10668481)

  • 1. Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors.
    Chan R; Muller WJ; Siegel PM
    Ann N Y Acad Sci; 1999; 889():45-51. PubMed ID: 10668481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer.
    Muller WJ; Ho J; Siegel PM
    Biochem Soc Symp; 1998; 63():149-57. PubMed ID: 9513719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
    Siegel PM; Dankort DL; Hardy WR; Muller WJ
    Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.
    Siegel PM; Ryan ED; Cardiff RD; Muller WJ
    EMBO J; 1999 Apr; 18(8):2149-64. PubMed ID: 10205169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation.
    Siegel PM; Muller WJ
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):8878-83. PubMed ID: 8799121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
    Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
    Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
    Podsypanina K; Li Y; Varmus HE
    BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.
    Andrechek ER; Hardy WR; Siegel PM; Rudnicki MA; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3444-9. PubMed ID: 10716706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
    Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ
    Cancer Res; 2003 Aug; 63(16):4920-6. PubMed ID: 12941816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene.
    Weinstein EJ; Kitsberg DI; Leder P
    Mol Med; 2000 Jan; 6(1):4-16. PubMed ID: 10803404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
    Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
    Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
    Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
    Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V
    Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egr-1 is required for neu/HER2-induced mammary tumors.
    Oh S; Kim H; Nam K; Shin I
    Cell Signal; 2018 May; 45():102-109. PubMed ID: 29408223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.